Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Fast shipping and welk packaged
A small clinical trial confirmed these findings, showing that exenatide, another GLP-1 agonist, significantly reduced intracranial pressure in patients with idiopathic intracranial hypertension, greatly improving headache symptoms
Persistent sadness, loss of interest, or feeling hopeless alongside fatigue may indicate depression
Eligibility depends on measurable health criteria rather than interest alone
To our knowledge, this is the first randomised, double-blind, placebo-controlled trial investigating the impact of GLP-1 receptor agonist treatment following LAGB insertion
US$ 28.37
US$ 28.04
US$ 20.08
US$ 22.40
US$ 26.82
US$ 25.29
US$ 28.86
